Literature DB >> 9723679

The output of budesonide from nebulizers.

P W Barry1, C O'Callaghan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9723679     DOI： 10.1016/s0091-6749(98)70103-4

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  4 in total

1.  Asthma drug delivery devices for children.

Authors:  C O'Callaghan; P W Barry
Journal:  BMJ       Date:  2000-03-11

Review 2.  Antiasthmatic drug delivery in children.

Authors:  Elizabeth Biggart; Andrew Bush
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

3.  Dose-response to salbutamol via a novel palm sized nebuliser (Aerodose Inhaler), conventional nebuliser (Pari LC Plus) and metered dose inhaler (Ventolin Evohaler) in moderate to severe asthmatics.

Authors:  Brian J Lipworth; Erika J Sims; Karla Taylor; Wendy Cockburn; Robert Fishman
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

Review 4.  Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders.

Authors:  K M Hvizdos; B Jarvis
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.